Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
The Veterinary Record|November 29, 2005
Survey of zoonoses recorded in Scotland between 1993 and 2002W C Stewart, K G J Pollock, L M Browning, et al.
Atherosclerosis|November 1, 1991
The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a)S Lamon-Fava, D Jimenez, J C Christian, et al.
Eye (London, England)|June 16, 2007
Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed componentsA G P Konstas, I E Katsimpris, K Kaltsos, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1990
High density lipoprotein cholesterol. A 16-year longitudinal study in aging male twinsJ C Christian, D Carmelli, W P Castelli, et al.
Journal of Animal Science|February 15, 2013
Organic and inorganic selenium: IV. passive transfer of immunoglobulin from ewe to lambW C Stewart, G Bobe, W R Vorachek, et al.
Ophthalmic Surgery and Lasers|July 23, 1998
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-CA R Kent, H B Dubiner, R Whitaker, et al.
European Journal of Ophthalmology|December 28, 2006
The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucomaG Holló, D Chiselita, N Petkova, et al.
American Journal of Ophthalmology|August 6, 2000
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressureW C Stewart, E D Sharpe, T S Harbin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 2, 2001
Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertensionW C Stewart, D G Day, J A Stewart, et al.
Eye (London, England)|April 20, 2004
Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertensionE D Sharpe, C J Henry, T K Mundorf, et al.
Pageof 30